Abstract
Cigarette smoking is strongly correlated with many diseases like cancer, cardiovascular disease and macular degeneration. Nicotine, the main active and addictive component of tobacco smoke has recently been shown to enhance angiogenesis in many experimental systems and animal models. The pro-angiogenic activity of nicotine is mediated by nicotinic acetylcholine receptors, particularly the alpha 7 subunit, that are expressed on a variety of non-neuronal cells including those in the vasculature such as endothelial cells and smooth muscle cells. The present review focuses on the role of α7nAChR in mediating the pro-angiogenic effects of nicotine and describes the molecular mechanisms involved in nicotine-induced angiogenesis as well as epithelial to mesenchymal transition. These observations on nicotine function highlight the therapeutic potential of α7nAChR agonists and antagonists for combating angiogenesis related diseases.
Keywords: signaling, arteriogenesis, macular degeneration, cancer, metastasis, smoking, cholinergic system, angiogenesis, neovascularization, EMT
Current Drug Targets
Title:α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Volume: 13 Issue: 5
Author(s): Smitha Pillai and Srikumar Chellappan
Affiliation:
Keywords: signaling, arteriogenesis, macular degeneration, cancer, metastasis, smoking, cholinergic system, angiogenesis, neovascularization, EMT
Abstract: Cigarette smoking is strongly correlated with many diseases like cancer, cardiovascular disease and macular degeneration. Nicotine, the main active and addictive component of tobacco smoke has recently been shown to enhance angiogenesis in many experimental systems and animal models. The pro-angiogenic activity of nicotine is mediated by nicotinic acetylcholine receptors, particularly the alpha 7 subunit, that are expressed on a variety of non-neuronal cells including those in the vasculature such as endothelial cells and smooth muscle cells. The present review focuses on the role of α7nAChR in mediating the pro-angiogenic effects of nicotine and describes the molecular mechanisms involved in nicotine-induced angiogenesis as well as epithelial to mesenchymal transition. These observations on nicotine function highlight the therapeutic potential of α7nAChR agonists and antagonists for combating angiogenesis related diseases.
Export Options
About this article
Cite this article as:
Smitha Pillai and Srikumar Chellappan , α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition , Current Drug Targets 2012; 13 (5) . https://dx.doi.org/10.2174/138945012800398847
DOI https://dx.doi.org/10.2174/138945012800398847 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chronic Kidney Disease - Different Role for HDL?
Current Medicinal Chemistry Human Adipose-Derived Stem Cells with Great Therapeutic Potential
Current Stem Cell Research & Therapy New Trends in Thromboxane and Prostacyclin Modulators
Current Medicinal Chemistry Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology Selenium and Selenoproteins: An Overview on Different Biological Systems
Current Protein & Peptide Science Does Data Shape Moral Decision? Or Do Values Shape the Data?
Current Pediatric Reviews Meet Our Associate Editor
Current Cardiology Reviews The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases
Current Protein & Peptide Science Measuring the Burden of Disease in the United Arab Emirates, 1990 – 2019: A Road to Future
New Emirates Medical Journal RAGE in Diabetic Nephropathy
Current Molecular Medicine The Location of Vascular Flap is Related with Daily Activity Patterns in Non-traumatic Acute Aortic Syndrome in a Chinese Population
Current Signal Transduction Therapy Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Vulnerable Plaque Versus Vulnerable Patient: Emerging Blood Biomarkers for Risk Stratification
Endocrine, Metabolic & Immune Disorders - Drug Targets Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity
Current Chemical Biology 3, 5-Diiodothyronine: Biological Actions and Therapeutic Perspectives
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cellular Mechanisms of the Protective Effect of Polyphenols on the Neurovascular Unit in Strokes
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting Resveratrol to Mitochondria for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Common Features of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Reviews on Recent Clinical Trials Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design